ID: ALA5191718

Max Phase: Preclinical

Molecular Formula: C31H49N3O6

Molecular Weight: 559.75

Associated Items:

Representations

Canonical SMILES:  CC(/C=C/[C@H]1O[C@H](C)C[C@@]2(CO2)[C@@H]1O)=C\C[C@@H]1O[C@H](C)[C@H](NC(=O)/C=C\[C@H](C)NC(=O)N2CCCCC2)C[C@@H]1C

Standard InChI:  InChI=1S/C31H49N3O6/c1-20(10-13-27-29(36)31(19-38-31)18-23(4)39-27)9-12-26-21(2)17-25(24(5)40-26)33-28(35)14-11-22(3)32-30(37)34-15-7-6-8-16-34/h9-11,13-14,21-27,29,36H,6-8,12,15-19H2,1-5H3,(H,32,37)(H,33,35)/b13-10+,14-11-,20-9+/t21-,22-,23+,24+,25+,26-,27+,29+,31+/m0/s1

Standard InChI Key:  ZHUAXJGBLXMCFV-DUEPXHNKSA-N

Associated Targets(Human)

MES-SA/Dx5 643 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MES-SA 905 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HEK-293T 167025 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 559.75Molecular Weight (Monoisotopic): 559.3621AlogP: 3.62#Rotatable Bonds: 8
Polar Surface Area: 112.66Molecular Species: NEUTRALHBA: 6HBD: 3
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 12.91CX Basic pKa: CX LogP: 2.45CX LogD: 2.45
Aromatic Rings: 0Heavy Atoms: 40QED Weighted: 0.24Np Likeness Score: 1.59

References

1. Ghosh AK, Mishevich JL, Jurica MS..  (2021)  Spliceostatins and Derivatives: Chemical Syntheses and Biological Properties of Potent Splicing Inhibitors.,  84  (5.0): [PMID:33974423] [10.1021/acs.jnatprod.1c00100]

Source